HealthOther

Almost 600,000 inhalers were just voluntarily recalled nationwide by GlaxoSmithKline due to a “defective delivery system,” with a large number of units having “out of speculation results for leak rate.”

The affected lot numbers are 6ZP0003, 6ZP9944, and 6ZP9848. The devices have been recalled from hospitals, pharmacies, retailers and wholesalers in the United States.

“There is possible risk that the affected inhalers could potentially not deliver the stated number of actuations,” spokesman Juan Carlos Molina wrote in an email. “We continue to investigate the issue in order to identify the root cause and implement appropriate corrective and preventative actions.”

The FDA describes the affected inhalers as prescription-only “Ventolin HFA (alb uterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 metered inhalations, net weight 18 g inhalers.” The recall is classified as “Class II,” which means “the products might cause temporary health problems, or pose only a slight threat of serious nature,” the FDA reports.

To see if your inhaler or your child’s inhaler is affected by this recall, check out the lot numbers below and the expiration dates.

  • 6ZP9848 (expiration date: March 2018)
  • 6ZP0003 (expiration date: April 2018)
  • 6ZP9944 (expiration date: April 2018)